Cellectis S.A. (CLLS)
NASDAQ·Healthcare·Biotechnology
$3.96
-1.25%
Mkt Cap $361.10M
Next Earnings
In 12 daysMon, May 11, 2026
EPS Estimate
-$0.28
5 analysts
Revenue Estimate
$12.09M
Last quarter: missed by -27.87% on EPS, -8.87% on revenue.
EPS — Estimate vs Actual
Mkt Cap
$361.10M
P/E
—
Fwd P/E
—
P/S
3.98
Rev TTM
—
EPS TTM
-$0.68